FDA Panel Recommends RSV Shot to Protect Infants

FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

Study shows key role for human T cells in the control of Respiratory Syncytial Virus (RSV) infection

FDA approves a topical, HSV-1 vector-based gene therapy for rare skin disorder.